Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
Neuronetics (STIM) Announces Launch of Underwritten Public Offering of Common Stock
-
Neuronetics Announces Launch of Underwritten Public Offering of Common Stock
-
Neuronetics and Greenbrook TMS Announce Closing of Transaction
-
Neuronetics (STIM) PT Lowered to $3 at Canaccord Genuity
-
Neuronetics (STIM) and Greenbrook TMS Announce Definitive Agreement to Merge
-
Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge
-
Neuronetics to Present at the Canaccord Genuity 44th Annual Growth Conference
-
Neuronetics to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
Neuronetics (STIM) PT Lowered to $9 at Canaccord Genuity
-
Neuronetics (STIM) PT Lowered to $15 at Canaccord Genuity
-
Neuronetics to Present at the Canaccord Genuity 41st Annual Growth Conference
-
Neuronetics Announces Closing of Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
-
Neuronetics Inc. (STIM) Prices 4.84M Share Common Offering at $15.50/Sh
-
Neuronetics Announces Pricing of $75 Million Public Offering of Common Stock
-
Neuronetics to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum
-
Neuronetics to Present at the 39th Annual Canaccord Genuity Growth Conference
-
Neuronetics to Present at the 39th Annual Canaccord Genuity Growth Conference
-
Canaccord Genuity Starts Neuronetics (STIM) at Buy
-
Neuronetics, Inc., Maker of NeuroStar® Advanced Therapy, Announces Closing of Initial Public Offering and the Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
-
Neuronetics (STIM) IPO Opens 41% Higher
-
Neuronetics, Inc. (STIM) Prices 5.5M Share IPO at $17/Sh
-
Neuronetics, Inc., Maker of NeuroStar® Advanced Therapy, Announces Pricing of Initial Public Offering
-
Neuronetics Files $86M IPO; Plans to List Under Symbol 'STIM'

